Drug Utilization Review Board

Regulatory
January 26, 2024
  • Twitter
  • Facebook
  • Google+
  • Linkedin
Drug Utilization Review Board develops and submits recommendations for the preferred drug list, suggests clinical prior authorizations on outpatient prescription drugs, recommends education interventions for Medicaid providers, and reviews drug usage across Medicaid programs. Members: Alejandro D. Kudisch, M.D., D.F. A.P.A. (McAllen) (Chair) Jennifer Fix, Pharm. D (Burleson) (Vice-chair) Scott Blaszczyk, Pharm.D., BCGP (Dallas) Marlo Brawner, M.D. (Livingston) Dominique Brewster, Pharm.D, BCPS, BCGP, AAHIVP (Houston) Deborah E. Briggs, M.D. (Austin) Term ends Aug. 31, 2023 Robert L. Hogue, M.D., F.A.A.F.M. (Brownwood) Term ends Aug. 31, 2023 Heather Holmes, M.D. (Amarillo) Sarah E. Kubes, Pharm. D. (San Antonio) Jill N. Lester, Pharm. D. (Dallas) Brigetta Martinez, Pharm. D., BCPPS, MASPHM (Edinburg) Richard Noel, M.D. (Spring) Term ends Aug. 31, 2023 Kim Pham, D.O. (Dallas) Term ends Aug. 31, 2023 Joshua R. Tonche-Johns, Phar

Subscribe to gain full access to all of our must-have reports and videos

OR

Log in